Clinical Study Results
How many participants had adverse events?
A similar percentage of participants in Part A and Part B had adverse events.
A similar percentage of participants in Part A and Part B had serious adverse events.
None of the participants in Part A stopped treatment because of adverse events they
had during the study. Some of the participants in Part B stopped treatment because of
adverse events they had during the study.
The table below shows how many participants had adverse events during the study.
Adverse events during the study
Part A 200 mg Part A 175 mg Part B 175 mg
AZD1775 AZD1775 AZD1775 Total
(out of 7 (out of 5 (out of 80 (out of 92
participants) participants) participants) participants)
How many
participants had
100.0% (7) 80.0% (4) 97.5% (78) 96.7% (89)
adverse events
during the study?
How many
participants had
serious adverse 14.3% (1) 40.0% (2) 22.5% (18) 22.8% (21)
events during the
study?
How many
participants
stopped
0.0% (0) 0.0% (0) 16.3% (13) 14.1% (13)
treatment
because of
adverse events?
6